Jeonjinbio Co. Ltd (110020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩313.21 Million ≈ $212.26K USD) by net assets (₩17.72 Billion ≈ $12.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jeonjinbio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Jeonjinbio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jeonjinbio Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Jeonjinbio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Smartlink Holdings Limited
NSE:SMARTLINK
0.022x
Copaur Minerals Inc
V:CPAU
-0.008x
Pelikan International Corp
KLSE:5231
-0.039x
Perfect Moment Ltd.
NASDAQ:PMNT
-7.386x
Anugerah Kagum Karya Utama Tbk PT
JK:AKKU
0.000x
Toppoint Holdings Inc.
NYSE MKT:TOPP
-0.049x
3R Games SA
WAR:3RG
0.038x
Sambhaav Media Limited
NSE:SAMBHAAV
-0.007x

Annual Cash Flow Conversion Efficiency for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Jeonjinbio Co. Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩17.66 Billion
≈ $11.97 Million
₩3.01 Billion
≈ $2.04 Million
0.170x +452.06%
2023-12-31 ₩6.22 Billion
≈ $4.21 Million
₩-300.60 Million
≈ $-203.71K
-0.048x +87.61%
2022-12-31 ₩9.51 Billion
≈ $6.44 Million
₩-3.71 Billion
≈ $-2.51 Million
-0.390x -76.65%
2021-12-31 ₩10.80 Billion
≈ $7.32 Million
₩-2.38 Billion
≈ $-1.62 Million
-0.221x -7.88%
2020-12-31 ₩11.28 Billion
≈ $7.65 Million
₩-2.31 Billion
≈ $-1.57 Million
-0.205x +54.32%
2019-12-31 ₩2.90 Billion
≈ $1.96 Million
₩-1.30 Billion
≈ $-880.34K
-0.448x +18.90%
2018-12-31 ₩3.91 Billion
≈ $2.65 Million
₩-2.16 Billion
≈ $-1.46 Million
-0.553x +69.24%
2017-12-31 ₩229.96 Million
≈ $155.84K
₩-413.19 Million
≈ $-280.01K
-1.797x -2154.30%
2016-12-31 ₩2.28 Billion
≈ $1.55 Million
₩-181.90 Million
≈ $-123.27K
-0.080x +94.83%
2015-12-31 ₩1.27 Billion
≈ $858.87K
₩-1.95 Billion
≈ $-1.32 Million
-1.541x --

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals
Market Cap
$14.37 Million
₩21.20 Billion KRW
Market Cap Rank
#25946 Global
#1939 in Korea
Share Price
₩2340.00
Change (1 day)
-1.68%
52-Week Range
₩1792.00 - ₩4445.00
All Time High
₩16700.00
About

Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 200… Read more